Summary of Directors' Ongoing Compensation for Pluristem Therapeutics Inc. Non-Executive Directors

Contract Categories: Human Resources › Compensation Agreements
Summary

This document outlines the compensation structure for non-executive directors of Pluristem Therapeutics Inc. as of September 10, 2020. Non-executive directors receive an annual cash payment of $35,000, with additional fees and equity awards for serving on or chairing the Audit, Compensation, or Nominating Committees. In special cases, directors may receive bonuses of up to $75,000 for exceptional performance, with further discretionary bonuses possible at the Board's or Compensation Committee's discretion.

Read More Arrow
EX-10.8 5 f10k2020ex10-8_pluristem.htm SUMMARY OF DIRECTORS' ONGOING COMPENSATION

Exhibit 10.8

 

Summary of Directors Ongoing Compensation

 

Effective as September 10, 2020, our non-executive officer directors receive cash compensation as follows:

 

●Annual compensation of $35,000;

 

●The Chairman of our Audit Committee shall receive an additional annual fee of $10,000 and in the event of an annual equity grant issued to directors, or an Annual Director Grant, an additional 10% of equity securities in addition to such grant, and each other member of the Audit Committee shall receive an additional annual fee of $3,000 and, in the event of an Annual Director Grant, an additional 3% of equity securities in addition to such grant;

 

●The Chairman of our Compensation Committee shall receive an additional annual fee of $4,000 and, in the event of an Annual Director Grant, an additional 4% of equity securities in addition to such grant, and each other member of the Compensation Committee shall receive an additional annual fee of $2,000 and, in the event of an Annual Director Grant, an additional 2% of equity securities in addition to such grant; and

 

●The Chairman of our Nominating Committee shall receive an additional annual fee of $4,000 and, in the event of an Annual Director Grant, an additional 4% of equity securities in addition to such grant, and each other member of the Nominating Committee shall receive an additional annual fee of $2,000 and, in the event of an Annual Director Grant, an additional 2% of equity securities in addition to such grant.

 

In exceptional circumstances, our non-executive directors may receive bonuses of up to $75,000 per year for extraordinary performance, as well as discretionary bonuses in special circumstances as the Board of Directors or the Compensation Committee may decide.